TW503231B - Method for preparing 3-aminot-1,2-propandiol derivatives - Google Patents

Method for preparing 3-aminot-1,2-propandiol derivatives Download PDF

Info

Publication number
TW503231B
TW503231B TW88119264A TW88119264A TW503231B TW 503231 B TW503231 B TW 503231B TW 88119264 A TW88119264 A TW 88119264A TW 88119264 A TW88119264 A TW 88119264A TW 503231 B TW503231 B TW 503231B
Authority
TW
Taiwan
Prior art keywords
formula
compound
scope
patent application
manufacturing
Prior art date
Application number
TW88119264A
Other languages
Chinese (zh)
Inventor
Bing-Jiun Wang
Jia-Wen Jang
Original Assignee
Everlight Chem Ind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everlight Chem Ind Corp filed Critical Everlight Chem Ind Corp
Priority to TW88119264A priority Critical patent/TW503231B/en
Application granted granted Critical
Publication of TW503231B publication Critical patent/TW503231B/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method for the preparation of 3-amino-1,2-propandiol derivatives of the formula (I) by reacting a compound of the formula (II) with RNH2, wherein R and R1 have the same meaning as given in the description. The formula (I) derivatives are β-blockers used for treating hypertension.

Description

503231 五、發明說明(/ ) [發明技術領域] 本發明係關於一種3_胺基妙丙二醇(3_—,2_ propandiol)衍生物之製造方法。特別是有關於—種使用同 —合成㈣’就可合成出各種不同可治療高血壓之阻斷 劑藥物的合成製造方法。 [發明技術背景] 很多治療高血壓的冷_阻斷劑藥物,如(s)_Tim〇1〇l、(s)_ Propranolo卜(S)-Aten〇l〇i 及(S)_Met〇pr〇1〇1 都共同具有 3 胺 基-1,2-丙二醇主結構。 請 先 閱 讀 背 面 之 注 意 事503231 V. Description of the Invention (/) [Technical Field of the Invention] The present invention relates to a method for producing a 3-amino-propanediol (3-propandiol) derivative. In particular, it relates to a method for synthesizing various kinds of blocker drugs capable of treating hypertension by using the same synthetic osmium. [Technical Background] Many cold-blocking drugs for treating hypertension, such as (s) _Tim〇101, (s) _ Propranolo (S) -Aten〇l〇i and (S) _Met〇pr〇. Both of them have a main structure of 3 amino-1,2-propanediol. Please read the note on the back first

XX

NHNH

S I NS I N

(S)-Timolol(S) -Timolol

(S)-Propranolol η < 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 503231 A7 B7 五、發明說明(>(S) -Propranolol η < Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 503231 A7 B7 V. Description of the invention (>

NHNH

CH2CONH2 (S)-Metoprolol 經濟部智慧財產局員工消費合作社印製 NH HOv^1。普 (S)-Atenolol 上述這些可治療高血壓的卢_阻斷劑藥物,雖然也有很 多合成方法被開發出來,但都是以各自單一製程,分別合成 出所需的藥物,例如,Weinstock,L. M ; MulYey,D. M ; TuUR· J· Org· Chem· 1976, 41,3121·有合成(S)-Tim〇l〇l 方法的報 導’但由於此製程有使用到四醋酸鉛(Pb〇AC4 ),在大量生 產時會有廢棄物處理的困擾。另外,Carlsen,P. H. J.; Aase,K Acta· Chem· Scand· 1993, 737·亦有合成(S)-Propran〇i〇l 方法 的報導。 由於這些治療高血壓的阻斷劑藥物都共同具有3_胺 基-1,2-丙二醇主結構,如果能夠基於上述這些藥物具有部分 的共同結構,而能夠開發出一種製造方法,只要選用適當的 -CH2CH2OCH3 (請先閱讀背面之注意事項再填寫本頁)CH2CONH2 (S) -Metoprolol Printed by NH HOv ^ 1, Consumer Cooperative of Intellectual Property Bureau, Ministry of Economic Affairs. General (S) -Atenolol The above-mentioned anti-hypertensive drugs can be used to treat hypertension. Although many synthetic methods have been developed, they all use separate processes to synthesize the required drugs. For example, Weinstock, L M; MulYey, D. M; TuUR · J · Org · Chem · 1976, 41, 3121 · Synthetic (S) -Timoll 101 method has been reported 'but lead tetraacetate (Pb〇) is used in this process. AC4), there will be a problem of waste disposal during mass production. In addition, Carlsen, P. H. J .; Aase, K Acta. Chem. Scand. 1993, 737. There are also reports on the synthetic (S) -Propranoliol method. Since these blockers for the treatment of hypertension all have a 3-amino-1,2-propanediol main structure, if one can develop a manufacturing method based on the fact that these drugs have a partial common structure, as long as the appropriate -CH2CH2OCH3 (Please read the notes on the back before filling this page)

訂---------^9— 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) A7 A7 ORi 經濟部智慧財產局員工消費合作社印製Order --------- ^ 9— This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) A7 A7 ORi Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs

五、發明說明(多 原料,就可以用同一合成路徑入士 &續仏,合成出上述各種不同藥物的 話,應當是頗具價値。 [發明之概述] 本發月之目6勺主要為提供一種合成製造%胺基 丙二醇衍生物的方法。 本發月之另目的,是提供一種只要選用適當的原料, 就可以用同口成路控,合成製造各種不同可用來治療高血 壓的/?-阻斷劑藥物的製程。 用來治療高血壓的々_阻斷劑藥物例如(s)_Tim〇1〇1、(s)_ Propranolo卜(8)-Αίθη〇1〇1及(^,紂叩⑺丨❹丨等等藥物,它們 可以涵蓋於如下之式⑴之3-胺基-1,2-丙二醇衍生物,V. Description of the invention (multiple raw materials, you can use the same synthetic route to enter the scholarship & continue to synthesize the various drugs mentioned above, it should be quite valuable. [Summary of the invention] 6 spoons of the head of this issue is mainly to provide a Method for synthesizing% amine propylene glycol derivative. Another purpose of this month is to provide a method for synthesizing various kinds of /?-Resistances which can be used to treat hypertension by selecting the proper raw materials. Manufacturing process of sedative drugs. 々_Blocker drugs used to treat hypertension such as (s) _Tim〇101, (s) _ Propranolo Bu (8) -Αίθη〇101 and (^, 纣 叩 ⑺丨 ❹ 丨 and other drugs, they can be covered by the 3-amino-1,2-propanediol derivative of the formula ,,

RNH Η0七 (I) 其中其中R代表Cij烷基, N “ CH2CONH2 或 泰紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁}RNH Η07 (I) where R stands for Cij alkyl, N "CH2CONH2 or Thai paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) (Please read the precautions on the back before filling out this page}

A7 五、發明說明(牛) ch2ch2och3 發明人基於上述這些藥物都是屬於3-胺基-at 衍生物,而開發出只要選用適當的原料,就可以用同— 路徑,合成出上述各種不同藥物的製程。 本發明之製造方法可以由如下之反應式(a)簡單表示 ‘醇 合成 閱 面 之 iiA7 V. Description of the invention (bovine) ch2ch2och3 Based on the above-mentioned drugs are 3-amino-at derivatives, the inventors have developed the same-path to synthesize the above-mentioned various drugs as long as the appropriate raw materials are selected. Process. The production method of the present invention can be simply expressed by the following reaction formula (a): ii of alcohol synthesis

Tr2N02STr2N02S

訂 H0Order H0

(iy-〇Ri 經濟部智慧財產局員工消費合作社印製 h2nr 〇·(iy-〇Ri Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs h2nr 〇 ·

(II) ORi 反應式(a) 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) r2so2q HO.(II) ORi reaction formula (a) This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) r2so2q HO.

ORi (π ΟcVRi R2S02C1ORi (π ΟcVRi R2S02C1

ch2conh2 或 川3231 A7 B7 五、發明說明({) 其中 R代表Ci·4烷基;較佳的,R代表代表異丙基、第四丁 基;ch2conh2 or Chuan 3231 A7 B7 V. Description of the invention ({) where R represents Ci · 4 alkyl; preferably, R represents isopropyl and fourth butyl;

Ri代表Ri stands for

R2代表Ci-4烷基、苯基、苯甲基、或經Ci-4烷基或鹵 素取代之苯基;較佳的,R2代表代表甲基、苯基或苯甲基; 關於式(VI)化合物之合成,在 Hsu,C.Y.; Lin,Y.S·; Uang,B.J,R2 represents Ci-4 alkyl, phenyl, benzyl, or phenyl substituted with Ci-4 alkyl or halogen; preferably, R2 represents methyl, phenyl, or benzyl; with respect to formula (VI ) Synthesis of compounds in Hsu, CY; Lin, YS ·; Uang, BJ,

Tetrahedron : Asymmetry 1990,1,219 文獻中,敎導以丙三 醇為原料,使用掌性辅助基,使進行不對稱縮酮化反應後, 可以得到上述式(VI)化合物,參見如下反應式(b)。Tetrahedron: Asymmetry 1990, 1,219 In the literature, glycerol is used as a raw material and a palm auxiliary group is used to perform an asymmetric ketalization reaction to obtain the compound of the above formula (VI). See the following reaction formula ( b).

本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐)This paper size applies to China National Standard (CNS) A4 (210 x 297 mm)

~ΟΪ —OH~ ΟΪ —OH

經濟部智慧財產局員工消費合作社印製Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs

五、發明說明(心 本發明首先選用式(VI)化合物,此化合物是一具有掌性 的丙一醇同等物(chiral glycerol equivalent ),在鹼的存在 下使與_燒基RiX進行進行取代反應,可以得到如式化 合物。其中所使用的溶劑可以是t_BuOH或DME (chmethoxyethane ),在迴流溫度下進行反應,在此所使用 的驗可以是t_BuOK、K2C03或NaH,其中以使用NaH可以 件到較佳的產率。 接著將式(V)化合物進一步於甲醇中以酸水解後,將可 更進一步,順利的得到式(IV)雙醇化合物。在此水解反應所 使用的酸可以例如鹽酸等。 然後再將式(IV)化合物以R2S〇2Cl(R2代表(^-4烷基、 苯基、苯甲基、或經d·4烷基或鹵素取代之苯基)轉換成 好的離去基,而得到式(III)化合物。式(111)化合物以NaH處 理’使進行分子内取代反應,可得式(11)環氧化合物。 式(H)環氧化合物,再使與燒基胺RNH2反應,其中R代表 c^4烷基,進行取代反應,就可以得到式⑴之3_胺基 丙二醇衍生物。 經濟部智慧財產局員工消費合作社印製 另外,關於由式(VI)化合物製備式(v)化合物之方法, 除了選用式(VI)化合物使與鹵烷基RlX進行進行取代反應, 可以得到如式(V)化合物之方法之外。亦可以選用式(VI)化合 物使與R2S〇2Cl進行取代反應以得到如下式(γι’)化合物,式 (vr)化合物再經以R1〇H處理可以得到如式(V)化合物,參見 8 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)~ ----— Α7 Β7 五、 發明說明(9) 如下之反應式(C ),V. Description of the invention (Here, the compound of formula (VI) is first selected in the present invention. This compound is a chiral glycerol equivalent, and a substitution reaction with a thiol RiX is performed in the presence of a base. The compound of formula can be obtained. The solvent used can be t_BuOH or DME (chmethoxyethane), and the reaction is carried out at reflux temperature. The test used here can be t_BuOK, K2C03 or NaH. After the compound of formula (V) is further hydrolyzed in methanol with acid, the bishydric compound of formula (IV) can be further obtained smoothly. The acid used in the hydrolysis reaction can be, for example, hydrochloric acid. The compound of formula (IV) is then converted into a good leaving group with R2S02Cl (R2 represents (^ -4 alkyl, phenyl, benzyl, or phenyl substituted with d.4 alkyl or halogen). The compound of formula (III) is obtained. The compound of formula (111) is treated with NaH to perform an intramolecular substitution reaction to obtain an epoxy compound of formula (11). The epoxy compound of formula (H) is then reacted with alkylamine RNH2 Reaction, where R stands for C ^ 4 alkyl group can be substituted to obtain the 3-amino propanediol derivative of formula 。. Printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs. In addition, the preparation of compounds of formula (v) from compounds of formula (VI) Method: In addition to selecting a compound of formula (VI) to perform a substitution reaction with a haloalkyl R1X, a method such as the compound of formula (V) can be obtained. Alternatively, a compound of formula (VI) can be used to perform a substitution reaction with R2SO2Cl to The compound of the following formula (γι ') is obtained, and the compound of the formula (vr) can be treated with R10H to obtain the compound of the formula (V). See 8 This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ) ~ ----— Α7 Β7 5. Explanation of the invention (9) The following reaction formula (C),

Prj2N〇2sPrj2N〇2s

〇Ri 經濟部智慧財產局員工消費合作社印製 於反應式(c)中取代基R2、Rl及X定義如前所述。 依本發明之製造方法,可以用來合成各種用來治療高血 壓的卢阻斷劑之化合物,如(S)-Timolol、(s)_Propranol〇l、 (S)-Atenolol 及(S)-Metoprolol 等藥物。 [發明之具體説明] 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) A7〇Ri Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs The definitions of the substituents R2, R1, and X in the reaction formula (c) are as described above. The manufacturing method according to the present invention can be used to synthesize various compounds of Lu blockers used for treating hypertension, such as (S) -Timolol, (s) -Propranol〇l, (S) -Atenolol and (S) -Metoprolol And other drugs. [Specific description of the invention] This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) A7

A7 RNH 五、發明說明(5) 本發明係有關一種如下式⑴之3_胺基β1,2-丙二醇(3_ ammo-l,2_ propandiol)衍生物之製造方法,A7 RNH 5. Description of the invention (5) The present invention relates to a method for producing a 3-amino β1,2-propanediol (3-ammo-1, 2-propandiol) derivative of the following formula:

H0OH0O

Lor! (i) 其中R代表代表Ci—4烷基;Ri代表^^ (請先閱讀背面之注意事項再填寫本頁)Lor! (I) where R stands for Ci-4 alkyl; Ri stands for ^^ (Please read the notes on the back before filling this page)

S I NS I N

CH2CONH2 或CH2CONH2 or

ch2ch2och3 1.齊部to曰i犲i苟員31省費^乍出.甲提 式(I)之合成可以如下式(II)化合物 ^ORi (II) 其中Rl定義如前所述,與烷基胺RNH2反應,其中R定義 如前所述。 該式(II)化合物之合成,係以如下式(IV)化合物 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 503231 A7 B7 五、發明說明(斤) Η丨ch2ch2och3 1. Qibu to said i 犲 i members 31 cost savings ^ first appeared. Synthesis of the formula (I) can be a compound of the formula (II) ^ ORi (II) where R1 is defined as described above, and alkyl Amine RNH2 reaction, where R is defined as previously described. The synthesis of the compound of formula (II) is based on the compound of formula (IV). The paper size applies to the Chinese National Standard (CNS) A4 (210 X 297 mm) 503231 A7 B7 V. Description of the invention (jins) Η 丨

Hoy '—OR! (IV) 其中Rl定義如前所述’與R^SC^Cl (其中R2定義如前所述) 反應後,再以NaH處理而得。 該式(IV)化合物之合成,何如可以如下式(VI)化合物Hoy '—OR! (IV) where R1 is defined as described above and reacted with R ^ SC ^ Cl (wherein R2 is defined as described above), and then treated with NaH. How can the synthesis of the compound of formula (IV) be as follows:

(請先閱讀背面之注意事^^填寫本頁) mm, 經濟部智慧財產局員工消費合作社印製 與鹵烷基RiX,其中Ri定義如前所述,X代表鹵素,相反 應後,再經水解反應而得。關於式(VI)化合物之製備可以參 考前述Hsu,C.Y·等人所發表之文獻,於此不再--贅述。 為方便更進一步説明起見,將列舉以下實施例做更具體 的説明。 [發明之較佳實施例] 以下實施例為本發明之具體説明,但不會因此而限定本 發明的範圍。 11 用中國國家標準(CNS)iT^格⑽x 297 〜- · i I I I I I - 線鲁· 503231 A7 B7 五、發明說明( 製備例(Please read the notes on the back ^^ Fill this page first) mm, printed by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs and haloalkyl RiX, where Ri is defined as described above, X stands for halogen, and then react with each other. Derived from hydrolysis reaction. With regard to the preparation of the compound of formula (VI), reference may be made to the aforementioned literature published by Hsu, C.Y. et al. For the convenience of further explanation, the following examples will be enumerated for more specific description. [Preferred Embodiments of the Invention] The following embodiments are specific descriptions of the present invention, but they do not limit the scope of the present invention. 11 Using Chinese National Standard (CNS) iT ^ Grid⑽ 297 ~-· i I I I I I-Line Lu · 503231 A7 B7 V. Description of the Invention (Preparation Example

CC

NaHNaH

將0.267克60% NaH置入50毫升反應瓶中,以2毫升 無水正己醇清洗2次,以眞空幫浦將溶劑抽乾後加入25毫 升無水DME (l,2-dimethoxyethane),並於冰溫下加入1.99克的 式(VI)化合物,然後再將 2.13 克的 3-chloro-4-(N-morpholino)-l,2,5-thiadiazole加入,並加熱迴流。反應完全後,於冰溫下加 入10毫升水,並以乙酸乙酯萃取,經管柱色層分析後,得 白色式(2)固體化合物2.732克,熔點:131.8〜132.6°(:,產率 95% 〇 (請先閱讀背面之注意事項再填寫本頁) -·續------ «Μ a··· a········ <*< μ··· Μ··· 一 經濟部智慧財產局員工消費合作社印製 12 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 503231 A7 B7 五、發明說明(") 製備例2Put 0.267 g of 60% NaH into a 50 ml reaction bottle, wash it twice with 2 ml of anhydrous n-hexanol, drain the solvent with a vacuum pump, and add 25 ml of anhydrous DME (l, 2-dimethoxyethane). Next, 1.99 g of the compound of formula (VI) was added, and then 2.13 g of 3-chloro-4- (N-morpholino) -1,2,5-thiadiazole was added, and heated under reflux. After the reaction was completed, 10 ml of water was added at ice temperature, and extracted with ethyl acetate. After column chromatography analysis, 2.732 g of a white solid compound of the formula (2) was obtained. Melting point: 131.8 ~ 132.6 ° (:, yield 95). % 〇 (Please read the precautions on the back before filling out this page)-· continued ------ «Μ a ·· a ······ < * < μ ··· Μ · ·· Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economy 12 This paper size is applicable to the Chinese National Standard (CNS) A4 (210 X 297 mm) 503231 A7 B7 V. Description of the invention (") Preparation Example 2

OH & 10OH & 10

K2C03, DMSOK2C03, DMSO

(請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 在致氣下’將式(9)化合物(2·68克,5.8毫莫耳)、K2CO (1.77克,12.9毫莫耳)、式(1〇)化合物(丨克,7·47毫莫耳 和無水DMSO (25毫升)置入已架上冷凝管之50毫升雙頸彥 應瓶中,並加熱至l〇〇°C反應22小時後,加入Η20 (20 | 升),以乙醚萃取(50毫升χ3),再以飽和食鹽水清洗,用冻 水硫酸鈉乾燥,經過濾和濃縮,以乙酸乙酯:正己烷=1 ·· 5 為沖提液,進行管柱色層分析得式(U)化合物,經以ΕΑ為 溶劑做再結晶,得白色固體式(Π)化合物(2·〇ι克,3.9毫莫 耳),熔點:170〜170.6°C,產率68%。 13 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 503231 A7 B7(Please read the precautions on the back before filling out this page) The Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs printed under the gas-generating 'compound of formula (9) (2.68 g, 5.8 mmol), K2CO (1.77 g , 12.9 millimoles), compound of formula (10) (丨 g, 7.47 millimoles and anhydrous DMSO (25 ml)) were placed in a 50 ml double-necked Yan Ying bottle with a condenser tube and heated to After reacting at 100 ° C for 22 hours, Η20 (20 | liters) was added, and extracted with ether (50 ml x 3), and then washed with saturated brine, dried over frozen sodium sulfate, filtered and concentrated, and ethyl acetate : N-hexane = 1 ·· 5 is the eluent, and column chromatography analysis is performed to obtain the compound of formula (U). After recrystallization using EA as a solvent, a white solid compound of (Π) (2. 00 g, 3.9 millimolar), melting point: 170 ~ 170.6 ° C, yield 68%. 13 This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) 503231 A7 B7

五、發明說明(/>) 製備例 HCl(aq)V. Description of the Invention (/ >) Preparation Example HCl (aq)

MeOH 50毫升反應瓶中置入1.53克式(2)化合物、7毫升甲醇, 及2.8毫升2N鹽酸,並加熱至60°c。反應完全後,於室溫 下加入3毫升水,並以NaOH中和至pH7〜8間,以乙酸乙酉旨 萃取,經過濾、濃縮後,得白色式(3)固體化合物0.652克, 熔點:122.8 〜123.4°C,產率 91% 。 製備例4 • ·1 n el emmmm n ϋ ϋ*-丨、a 1« «ϋ I JV—- t' T (請先閱讀背面之注意事項再填寫本頁)A 50 ml reaction bottle of MeOH was charged with 1.53 g of the compound of formula (2), 7 ml of methanol, and 2.8 ml of 2N hydrochloric acid, and heated to 60 ° C. After the reaction was completed, 3 ml of water was added at room temperature, neutralized with NaOH to pH 7 to 8, and extracted with ethyl acetate. After filtration and concentration, 0.652 g of a white solid compound of formula (3) was obtained. Melting point: 122.8 ~ 123.4 ° C, yield 91%. Preparation Example 4 • · 1 n el emmmm n ϋ ϋ *-丨, a 1 «« ϋ I JV—- t 'T (Please read the precautions on the back before filling in this page)

本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 厶J丄 A7 五、發明說明(/多)於25毫升星〃 x貝瓶中’加入式(11)化合物(2.01克,3·8ί毫莫耳)、甲醇Θ笔升)和2iV HC1 (aq) (4毫升,8毫莫耳 架上冷凝管後加埶至 , ^ y.…、主7〇C。經10小時後,冷卻至室溫加义 仏〇 (10毫升)’以1M Na〇H (aq)調pH值至7-8間,以乙 乙i曰萃取(5〇毫升χ3),有機層以飽和食鹽水清洗,用無 水硫酸鈉乾燥,經過濾和濃縮,以乙酸乙酯:正己烷=ι:, 為冲提液,進仃管柱色層分析後得白色固體式(12)化合物 (〇·766克3·51毫莫耳),產率為90%,炼點:111.2〜111.S °C,產率 95%。製備例5 · 經濟部智慧財產局員工消費合作社印製This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 厶 J 丄 A7 V. Description of the invention (/ multiple) In a 25ml starfish x shellfish bottle, add the compound of formula (11) (2.01g , 3 · 8 lmmoles), methanol Θ pen liters) and 2iV HC1 (aq) (4 ml, 8 molars on the condenser tube, then add 埶 to ^ y ...., the main 70 ° C. After 10 hours Then, it was cooled to room temperature, and added 仏 〇 (10mL) 'to adjust the pH to 7-8 with 1M NaOH (aq), and extracted with ethyl acetate (50mL × 3), and the organic layer was washed with saturated brine. , Dried over anhydrous sodium sulfate, filtered and concentrated with ethyl acetate: n-hexane = ι :, as the eluent, and analyzed by column chromatography to obtain a white solid compound of formula (12) (0 · 766 g 3 · 51 mmol), yield 90%, refining point: 111.2 ~ 111.S ° C, yield 95%. Preparation Example 5 · Printed by the Consumer Cooperative of Intellectual Property Bureau, Ministry of Economic Affairs

N N 、S〆 (3)N N 、 S〆 (3)

TsClTsCl

(4) N N 、S〆 將1.5克式(3)化合物置入以乾燥過之wo毫升反應瓶 15 表紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ---------^--------- <請先閱讀背面之注意事項再填寫本頁) 503231(4) NN, S〆 Put 1.5g of compound of formula (3) into dried woml reaction bottle 15 Table paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) ----- ---- ^ --------- < Please read the notes on the back before filling in this page) 503231

五、發明說明(4)V. Description of the invention (4)

中,再加入20毫升無水二氯甲烷和2·5毫升無水pyridine, 並於-5〜-10°C下,將1·2克氯磺酸甲苯(toluene sulfonyl chloride; TsCl )加入。反應完全後,於室加入毫升水, 並以二氯甲烷萃取,經過濾、濃縮及管柱色層分析後,得白 色式(4)固體化合物1.61克,產率68% 。 製備例6Then, 20 ml of anhydrous dichloromethane and 2.5 ml of anhydrous pyridine were added, and 1.2 g of toluene sulfonyl chloride (TsCl) was added at -5 to -10 ° C. After the reaction was completed, ml of water was added to the chamber, and the mixture was extracted with dichloromethane. After filtration, concentration, and column chromatography, 1.61 g of a white solid compound of the formula (4) was obtained with a yield of 68%. Preparation Example 6

TsO\ 將0.22克80% NaH置入以乾燥過之50毫升反應瓶中, 以2囊升播水正己醇清洗2次’再以2當升無水清洗1次, 在以眞空幫浦將溶劑抽乾後,加入12毫升無水THF,並於 冰溫下加入1.47克的式(4)化合物。反應完全後,於室加入 10毫升水,並以乙酸乙酯萃取,經過濾、濃縮及管柱色層 分析後,得白色式(5)固體化合物0.77克,產率90% 。 16 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ww I a··* MW I MM a··· · I · mmmmm ϋ ti I I 1 ϋ jriJ n n «I ϋ ϋ I · 胡填寫本頁) 經濟部智慧財產局員工消費合作社印製 經濟部智慧財產局員工消費合作社印製 503231 , A7 ___ B7 五、發明說明(A ) 實魂TsO \ Put 0.22g of 80% NaH into a 50ml reaction bottle which has been dried, and wash it twice with 2 liters of water and n-hexanol, and then wash it once with 2 liters of anhydrous water. After drying, 12 ml of anhydrous THF was added, and 1.47 g of the compound of formula (4) was added at ice temperature. After the reaction was completed, 10 ml of water was added to the chamber and extracted with ethyl acetate. After filtration, concentration and column chromatography analysis, 0.77 g of a white solid compound of formula (5) was obtained with a yield of 90%. 16 This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ww I a ·· * MW I MM a ··· · I · mmmmm ϋ ti II 1 ϋ jriJ nn «I ϋ ϋ I · (Hu fills in this page) Printed by the Employees 'Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Printed 503231, A7 ___ B7 V. Description of the Invention (A) Real Spirit

(S)-Timolol 10毫升反應瓶中.置入〇·15克式(5)化合物、7·0毫升第 四丁基胺,及〇·25毫升水,並加熱至迴流。反應完全後, 加入20毫升乙酸乙酯,經過濾、濃縮後,得(s)_Tirn〇l〇l白 色固體〇·19克,產率97% 。 實施例2 重衩製備例5、製備例6及實施例1之步驟,但改以式 (12)化合物取代式(3)化合物’並改以異丙胺(2-amino propane) 取代 t-BuNH2,可以得到(S)-Propranolol 0 、 .(S) -Timolol 10 ml reaction flask. 0.15 g of the compound of formula (5), 7.0 ml of tetrabutylamine, and 0.25 ml of water were placed and heated to reflux. After the reaction was completed, 20 ml of ethyl acetate was added, and after filtration and concentration, (19) g of (s) -Tirnoll was obtained as a white solid, 0.19 g in a yield of 97%. Example 2 The steps of Preparation Example 5, Preparation Example 6, and Example 1 were repeated, but the compound of formula (3) was replaced with a compound of formula (12) and t-BuNH2 was replaced with 2-amino propane. You can get (S) -Propranolol 0,.

[發明效果] 本發明是一種新穎而有效率的合成製造3_胺基-1,2-丙 二醇衍生物方法。是一種經由選用適當的原料,用同一合成 17 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -n I I I n I ϋ ϋ n 1 1 n I n n 一0*· » >ϋ I ϋ ϋ ·1 -I I I (請先閱讀背面之注意事項再填寫本頁) 503231 A7 B7 五、發明說明(4 路徑就可以合成製造出各種不同可用來治療高血壓的万-阻 斷劑,例如,(S)-Timolol、(S)-Propranolo卜(S)-Atenolol 及 (S)_Metoprolol等藥物的製程。 本發明所提供之製造方法,由於具有共同的合成路徑, 因此本發明在生產上述藥物時,設備可以共通,使本發明在 生產上具有更有利的優勢。 請 先 閱 讀 背 S) 之 注[Effects of the Invention] The present invention is a novel and efficient method for synthesizing and manufacturing 3-amino-1,2-propanediol derivatives. It is a kind of paper that is synthesized by selecting the appropriate raw materials and using the same 17 paper sizes. Applicable to China National Standard (CNS) A4 (210 X 297 mm) -n III n I ϋ 1 n 1 1 n I nn a 0 * · »> ϋ I ϋ ϋ · 1 -III (Please read the precautions on the back before filling out this page) 503231 A7 B7 V. Description of the invention (4 paths can be used to synthesize a variety of different 10,000-blockers that can be used to treat hypertension For example, (S) -Timolol, (S) -Propranolo, (S) -Atenolol, and (S) _Metoprolol and other drugs. The manufacturing method provided by the present invention has a common synthetic path, so the present invention is in production When the above medicines are used, the equipment can be shared, so that the present invention has more advantageous advantages in production. Please read the note of S)

訂 4 經濟部智慧財產局員工消費合作社印製Order 4 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs

8 1X 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐)8 1X This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)

Claims (1)

503231 A8 B8 C8 D8 六、申請專利範圍 公告503231 A8 B8 C8 D8 VI. Scope of patent application announcement RNH H0RNH H0 (I) 1· 一種如下式(I)之3-胺基-1,2 -丙二醇(3-amino-l,2_ propandiol)衍生物之製造方法, OR! 其中: R代表代表C!_4烷基 (請先閱讀背面之注意事項再填寫本頁)(I) 1. A method for producing a 3-amino-1,2-propandiol derivative of the formula (I), OR! Wherein: R represents C! _4 alkyl (Please read the notes on the back before filling this page) CH2CH2OCH3CH2CH2OCH3 CH2CONH2 或CH2CONH2 or 經濟部智慧財產局員工消費合作社印製 ORi 其包括以如下式(II)化合物 T (II) 其中Rl定義如前所述,與烷基胺RNH2反應,其中R代表 Ci—4烷基,其中該式(II)化合物係以如下式(IV)化合物 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 六、 申請專利範圍 ABQS HOThe ORi printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs includes the compound T (II) of the following formula (II), wherein R1 is defined as described above, and reacts with alkylamine RNH2, where R represents Ci-4 alkyl, where the The compound of formula (II) is the compound of formula (IV). The paper size is applicable to the Chinese National Standard (CNS) A4 (210 X 297 mm). VI. Application scope ABQS HO ORi (IV) 其中Ri定義如前所述,與R2S〇2Ci反應,其中r2代表匸】-、元基、丰基、苯甲基、或經Cl_4燒基或卣素取代之苯基, 再以NaH處理而得。 2·如申請專利範圍第1項之製造方法,其中R代表異丙基或 第四丁基。 3·如申請專利範圍第1項之製造方法,其中Rl代表 4 ------------ (請先閱讀背面之注意事項再填寫本頁)ORi (IV) where Ri is defined as previously described, and reacts with R2S02Ci, where r2 represents 匸]-, a radical, an acyl group, a benzyl group, or a phenyl group substituted with a Cl_4 alkyl group or a halogen compound, and then NaH treatment. 2. The manufacturing method according to item 1 of the application, wherein R represents isopropyl or fourth butyl. 3. If the manufacturing method of item 1 of the patent application scope, where Rl represents 4 ------------ (Please read the precautions on the back before filling this page) NN Ο 4.如申請專利範圍第1項之製造方法,其中該式⑴衍生物係 為如下之(S ) -Timolol。 ---:丨訂----- 線聲 經濟部智慧財產局員工消費合作社印製 X HO NH〇 4. The manufacturing method according to item 1 of the scope of patent application, wherein the derivative of formula (I) is (S) -Timolol as follows. ---: 丨 Order ----- Line Voice Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economy X HO NH N XTN XT 0 20 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) AS B8 C8 D8 六 、申請專利範圍 5 ·如申請專利範圍第1項之製造方法,其中該式(IV)化合物0 20 This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) AS B8 C8 D8 VI. Application for patent scope 5 · If the manufacturing method of the first scope of patent application, the compound of formula (IV) 0H 與卣烷基R][X,其中R〗定義如申請專利範圍第1項,X代 表鹵素,相反應後,再經水解反應而得。 如申請專利範圍第1項之製造方法,其中該式(IV)化合物 係以前述之式(VI)化合物與r2s〇2C1進行取代反應,其中 尺2定義如申請專利範圍第1項所述,經以RiOH處理後, 其中定義如申請專利範圍第1項,再經水解反應而得。 ------------丨^^-------,丨訂丨·--------線lip. (請先閱讀背面之注音?事項再填寫本頁} 經濟部智慧財產局員工消費合作社印製 標準(c^T4 規格(210_ 21 X 297公釐)0H and fluorene alkyl R] [X, where R is defined as in item 1 of the scope of patent application, and X represents halogen, which is obtained after a phase reaction followed by a hydrolysis reaction. For example, the manufacturing method of the first scope of the patent application, wherein the compound of formula (IV) is a substitution reaction of the aforementioned compound of the formula (VI) and r2s〇2C1, wherein the definition of rule 2 is as described in the first scope of the patent application. After treatment with RiOH, the definition is as in item 1 of the scope of patent application, and then obtained by hydrolysis reaction. ------------ 丨 ^^ -------, 丨 Order 丨 · -------- line lip. (Please read the phonetic on the back? Matters before filling in this Page} Printed Standard for Employee Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs (c ^ T4 specification (210_ 21 X 297 mm)
TW88119264A 1999-11-04 1999-11-04 Method for preparing 3-aminot-1,2-propandiol derivatives TW503231B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW88119264A TW503231B (en) 1999-11-04 1999-11-04 Method for preparing 3-aminot-1,2-propandiol derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW88119264A TW503231B (en) 1999-11-04 1999-11-04 Method for preparing 3-aminot-1,2-propandiol derivatives

Publications (1)

Publication Number Publication Date
TW503231B true TW503231B (en) 2002-09-21

Family

ID=27607538

Family Applications (1)

Application Number Title Priority Date Filing Date
TW88119264A TW503231B (en) 1999-11-04 1999-11-04 Method for preparing 3-aminot-1,2-propandiol derivatives

Country Status (1)

Country Link
TW (1) TW503231B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10096595B2 (en) 2015-10-28 2018-10-09 Globalfoundries Inc. Antenna diode circuit for manufacturing of semiconductor devices

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10096595B2 (en) 2015-10-28 2018-10-09 Globalfoundries Inc. Antenna diode circuit for manufacturing of semiconductor devices

Similar Documents

Publication Publication Date Title
FI87785C (en) FREQUENCY REQUIREMENT FOR PHARMACEUTICAL ACTIVATION, CRYSTALLINE PAROXETYHYDROCHLORIDE HEMIHYDRATE
EP1527048A2 (en) N- phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
KR20080043811A (en) Method of obtaining 3,3-diphenylpropylamines
WO2011076086A1 (en) Intermediate compounds of tamiflu, methods of preparation and uses thereof
AU2003208618B2 (en) A process for preparing a phenylalanine derivative and intermediates thereof
CA2769498A1 (en) Process for obtaining 3,3-diphenylpropylamines
TW503231B (en) Method for preparing 3-aminot-1,2-propandiol derivatives
RU2010108507A (en) PERCHARIDINES AS CDK INHIBITORS
JP5927126B2 (en) Process for producing 2- (cyclohexylmethyl) -N- {2-[(2S) -1-methylpyrrolidin-2-yl] ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide
CN1134149A (en) Phenylindole compounds
HU227114B1 (en) (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
CN113072486B (en) Amino alcohol-boron-binaphthol complex and preparation method of optically active amino alcohol derivative using same
JP5344523B2 (en) Catalyst capable of proceeding Strecker reaction stereoselectively, and method for stereoselectively producing an α-amino nitrile derivative using the same
WO2015081920A1 (en) Process for preparing lurasidone and intermediate thereof
KR100915666B1 (en) Synthetic method of optically pure (s)-3-hydroxypyrrolidine
WO2004039785A1 (en) Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
EP0522914A1 (en) 2-Piperidinylpyrimidin-4-carboxamide derivatives, their preparation and their application in therapy
RU2741389C1 (en) Method for preparing intermediate compound for synthesis of medicinal agent
JPS62209047A (en) Production of optically active beta-aminoalcohol
WO2011127794A1 (en) Chiral cyclic beta-amino aryl butyric acid derivatives, their preparation methods and methods for preparation of chiral beta-amino aryl butyric acid derivatives via them
JP4310284B2 (en) Nucleophilic addition reaction method of enamide to azo compounds
CN1733728A (en) Novel donepezil synthesis process
JP2009096744A (en) Mannich reaction by using cyclic aminoether
KR101446708B1 (en) Optically active ethylenediamine derivatives and prepartion method thereof
WO2019098551A1 (en) Method for preparing intermediate compound for synthesizing pharmaceutical

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees